Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing: earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures gives cross-border investors faster access to Tokyo-listed disclosures.
This corporate disclosure from Healthcare & Medical Investment Corporation was processed by Pulse News Wire on May 29, 2026. It represents a primary source document for Japanese Earnings sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.
TOKYO, May 29 (Pulse News Wire) – Healthcare & Medical Investment Corp. (3455.T) reported non-consolidated results for fiscal year 2026 ending January. Revenue was ¥2.7 billion. operating profit was ¥
View all Healthcare & Medical Investment Corporation disclosures →
Healthcare & Medical Investment Corporation [3455.T]
TOKYO, May 29 (Pulse News Wire) – Healthcare & Medical Investment Corp. (3455.T) reported non-consolidated results for fiscal year 2026 ending January.
Revenue was ¥2.7 billion. operating profit was ¥1,340 million.
Net profit was ¥997 million.
🟢 Confidence: High AI-translated content.